Advertisement

Pharmaceutical Chemistry Journal

, Volume 31, Issue 10, pp 536–539 | Cite as

Synthesis and study of psychotropic and hypotensive properties of new picamilon derivatives

  • V. M. Kopelevich
  • L. N. Bulanova
  • I. A. Grigor'ev
  • S. G. Gorbunov
  • A. V. Sabanov
  • V. L. Adzhienko
  • V. Ya. Il'in
  • V. N. Perfilova
  • I. N. Tyurenkov
  • V. I. Petrov
  • V. I. Gunar
Search for New Drugs
  • 79 Downloads

Keywords

Forced Swimming Test Dark Compartment Immobilization Time Blind Alley Isonicotinoyl 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    USSR Inventor's Certificate No. 325 232,Byull. Izobret., No. 3 (1972).Google Scholar
  2. 2.
    Picamilon in Modern Neurological and Psychiatric Practice [in Russian], “Vitaminy” Research and Production Association, Moscow (1994).Google Scholar
  3. 3.
    P. M. Vasil'ev, G. V. Kovalev, and N. V. Mukhina,Picamilon: A New Cerebrovascular and Nootropic Drug [in Russian], VNIISENTI, Moscow (1989), pp. 60–61.Google Scholar
  4. 4.
    T. A. Voronina, T. L. Garibova, I. V. Khromova, et al.,Farmakol. Toxicol.,50(3), 21–24 (1987).Google Scholar
  5. 5.
    T. A. Voronina and G. M. Molodavkin,Picamilon in Modern Neurological and Psychiatric Practice [in Russian], “Vitaminy” Research and Production Association, Moscow (1994), pp. 38–41.Google Scholar
  6. 6.
    E. A. Kuznetsova, T. A. Voronina, I. V. Khromova, et al.,Khim.-Farm. Zh.,23(12), 1425–1431 (1989).Google Scholar
  7. 7.
    L. A. Zhmurenko, S. A. Borisenko, O. M. Glozman, et al.,Khim.-Farm. Zh.,14(9), 45–55 (1980).Google Scholar
  8. 8.
    G. I. Kovalev, V. M. Kopelevich, L. N. Bulanova, et al.,Khim.-Farm. Zh.,13(10), 18–23 (1979).Google Scholar
  9. 9.
    K. Matsuyama, C. Yamashita, A. Noda, et al.,Chem. Pharm. Bull.,32, 4089–4095 (1984).PubMedGoogle Scholar
  10. 10.
    R. S. Mirzoyan, T. S. Gan'shina, and L. M. Shmuilovich,Byul. Eksp. Biol. Med., No. 11, 573–574 (1981).Google Scholar
  11. 11.
    T. A. Voronina, O. M. Glozman, L. M. Meshcheryakova, et al.,Khim.-Farm. Zh.,29(12), 134–37 (1995).Google Scholar
  12. 12.
    W. H. Gundel,Z. Naturforsch.,40B, 305–312 (1985).Google Scholar
  13. 13.
    R. A. Khaunina and I. P. Lapin,Khim.-Farm. Zh.,10(12), 125–127 (1976).Google Scholar
  14. 14.
    G. Pepeu,Alzheimer's Disease, (1989), pp. 387–398.Google Scholar
  15. 15.
    R. Porsolt, G. Anton, N. Blavet, et al.,Eur. J. Pharmacol.,47, 379–391 (1978).PubMedCrossRefGoogle Scholar
  16. 16.
    R. M. Salimov,Zh. Vyssh. Nerv. Deyat.,38 (3), 569–570 (1988).Google Scholar
  17. 17.
    J. Bures and O. Buresova,J. Physiol. Psychol.,56, 268–272 (1963).CrossRefGoogle Scholar
  18. 18.
    A. A. Krauklis,Self-Regulation of Higher Nervous Activity [in Russian], Riga (1964), p. 326.Google Scholar
  19. 19.
    N. A. Bondarenko,Author's Abstract of Cand. Sci. (Biol.) Thesis, Moscow (1992).Google Scholar
  20. 20.
    M. L. Belen'kii,Principles of the Quantitative Assessment of the Pharmacological Effect [in Russian], Medgiz, Leningrad (1963).Google Scholar
  21. 21.
    H. Takahashi and M. Tiba,Jpn. J. Physiol.,5, 334–339 (1955).PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1998

Authors and Affiliations

  • V. M. Kopelevich
    • 1
  • L. N. Bulanova
    • 1
  • I. A. Grigor'ev
    • 1
  • S. G. Gorbunov
    • 1
  • A. V. Sabanov
    • 1
  • V. L. Adzhienko
    • 2
  • V. Ya. Il'in
    • 2
  • V. N. Perfilova
    • 2
  • I. N. Tyurenkov
    • 2
  • V. I. Petrov
    • 2
  • V. I. Gunar
    • 2
  1. 1.“Vitaminy” Research and Production AssociationMoscowRussia
  2. 2.Volgograd Medical AcademyVolgogradRussia

Personalised recommendations